Page last updated: 2024-08-23

simvastatin and Hyperlipoproteinemia Type IV

simvastatin has been researched along with Hyperlipoproteinemia Type IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barberá, G; Chacón, P; Hernández, C; Lecube, A; Lima, J; Simó, R	1

Trials

1 trial(s) available for simvastatin and Hyperlipoproteinemia Type IV

Article	Year
Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men. Medical science monitor : international medical journal of experimental and clinical research, 2003, Volume: 9, Issue:3 Topics: Adult; Bezafibrate; Biomarkers; Chemokine CCL2; E-Selectin; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Inflammation Mediators; Lovastatin; Male; Middle Aged; Simvastatin; Vascular Cell Adhesion Molecule-1	2003

Article

Year

Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men.

Medical science monitor : international medical journal of experimental and clinical research, 2003, Volume: 9, Issue:3

Topics: Adult; Bezafibrate; Biomarkers; Chemokine CCL2; E-Selectin; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Inflammation Mediators; Lovastatin; Male; Middle Aged; Simvastatin; Vascular Cell Adhesion Molecule-1

2003